CD137 as a biomarker for tumor-reactive T cells: Finding gold in the desert

22Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Although human cancer is often surrounded by immune cells, only a small number are tumor-reactive T cells that recognize the tumor antigens and are able to eliminate the cancer cells. Ye and colleagues now found that many of these tumor-reactive T cells are marked by expressing CD137, a T-cell costimulatory receptor. Clin Cancer Res; 20(1); 3-5. © 2013 AACR.

Cite

CITATION STYLE

APA

Zhu, Y., & Chen, L. (2014). CD137 as a biomarker for tumor-reactive T cells: Finding gold in the desert. Clinical Cancer Research, 20(1), 3–5. https://doi.org/10.1158/1078-0432.CCR-13-2573

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free